Table 3: Bacterial isolates treated with tigecycline and microbiological response.
MRSA: methicillin-resistant Staphylococcus aureus, MSSA: methicillin-suscetible Staphylococcus aureus
a : Peptostreptococcus specie, .Morganella morganii, Citrobacter freundii,Prevotella species, Enterobacter aerogenes, Enterobacter cloacae, MRCNS
Bacterial isolates N Sampling site Positive response, N Negative response, N Uncertain, N Susceptibility to tigecycline (%)
Enterococcus faecium (VRE) 23 Blood 1
Urine 10
Abdomen 8
Lung 1
Skin and skin structure 3		 7 5 11 99
Enterococcus faecalis (VRE) 1 Blood 1 0 0 1 100
Enterococcus species 17 Abdomen 11
Skin and skin structure 6		 7 3 7 98
MRSA 14 Skin and skin structure 7
Abdomen 3
Lung 3
Otitis media 1		 2 7 5 99
Escherichia coli 9 Skin and skin structure 2(2ESBL)
Abdomen 5(3ESBL)
Lung 1(1ESBL)
Blood 1		 2 2 5 100
Klebsiella pneumoniae 3 Urine 1
Skin and skin structure 2(2ESBL)		 1 0 2 92
MSSA 3 Skin and skin structure 3 2 0 1 NA
Acinetobacter baumannii 106 Lung 87(83MDRAB))
Skin and skin structure 9(8MDRAB)
Urine 6(6MDRAB)
Abdomen 3(3MDRAB)
Blood 1		 9 59 38 26
Othersa 7 Skin and skin structure 5
Blood 1
Abdomen 1		 3 3 1 *
Total 183 33(18%) 79(43%) 71(39%) -